Amyloid plaques in retina for diagnosis in Alzheimer's patients: A meta-analysis

Frontiers in Aging Neuroscience

Volumn 8, Issue NOV, 2016, Pages

  Jiang, Jiangling ^a   Wang, Hongyan ^a   Li, Wei ^a   Cao, Xinyi ^a   Li, Chunbo ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Diagnosis; Meta analysis; Retina; amyloid peptides

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; CROSS-SECTIONAL STUDY; ELECTRONIC MEDICAL RECORD; FLUORESCENCE; HUMAN; LIMIT OF QUANTITATION; NEGATIVE LIKELIHOOD RATIO; PATHOGENESIS; POSITIVE LIKELIHOOD RATIO; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETINA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

EID: 85006326800     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2016.00267     Document Type: Article

References (33)

1. Alexandrov, P. N., Aileen, P., Surjyadipta, B., and Lukiw, W. J. (2011). Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease. Neuroreport 22, 623-627. doi: 10.1097/WNR.0b013e3283497334
2. Alzheimer's Association (2015). 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 11, 332-384. doi: 10.1016/j.jalz.2015.02.003
3. Ball, M., Braak, H., Coleman, P., Dickson, D., Duyckaerts, C., Gambetti, P., et al. (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18, S1-S2. doi: 10.1016/S0197-4580(97)00057-2
4. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., and Del Tredici, K. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389-404. doi: 10.1007/s00401-006-0127-z
5. Dutescu, R. M., Li, Q.-X., Crowston, J., Masters, C. L., Baird, P. N., and Culvenor, J. G. (2009). Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch. Clin. Exp. Ophthalmol. 247, 1213-1221. doi: 10.1007/s00417-009-1060-3
6. Frost, S., Kanagasingam, Y., Macaulay, L., Koronyo-Hamaoui, M., Koronyo, Y., Biggs, D., et al. (2014). Retinal amyloid fluorescence imaging predicts cerebral amyloid burden and Alzheimer's disease. Alzheimers Dement. 10, 234-235. doi: 10.1016/j.jalz.2014.04.341
7. Greenhalgh, T., and Peacock, R. (2005). Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 331, 1064-1065. doi: 10.1136/bmj.38636.593461.68
8. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
9. Higgins, J. P. T., and Green, S. (2008). Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley Online Library
10. Hinton, D. R., Sadun, A. A., Blanks, J. C., and Miller, C. A. (1986). Optic-nerve degeneration in Alzheimer's disease. N. Engl. J. Med. 315, 485-487. doi: 10.1056/NEJM198608213150804
11. Ho, C.-Y., Troncoso, J. C., Knox, D., Stark, W., and Eberhart, C. G. (2014). Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Brain Pathol. 24, 25-32. doi: 10.1111/bpa.12070
12. Horsley, T., Dingwall, O., and Sampson, M. (2011). Checking reference lists to find additional studies for systematic reviews. Cochrane Database Syst. Rev. 8:MR000026. doi: 10.1002/14651858.MR000026.pub2
13. Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. doi: 10.1016/S1474-4422(09)70299-6
14. Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R., et al. (2015). Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313, 1924-1938. doi: 10.1001/jama.2015.4668
15. Kandimalla, R. J., Prabhakar, S., Wani, W. Y., Kaushal, A., Gupta, N., Sharma, D. R., et al. (2013). CSF p-Tau levels in the prediction of Alzheimer's disease. Biol. Open 2, 1119-1124. doi: 10.1242/bio.20135447
16. Karran, E., Mercken, M., and De Strooper, B. (2011). The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698-712. doi: 10.1038/nrd3505
17. Kerbage, C., Hartung, P. D., Sadowsky, C., Tariot, P., Agronin, M., Alva, G., et al. (2014). Detection of ligand bound to beta amyloid in the lenses of human eyes. Alzheimers Dement. 10:173. doi: 10.1016/j.jalz.2014.04.184
18. Koronyo, Y., Salumbides, B. C., Black, K. L., and Koronyo-Hamaoui, M. (2012). Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment. Neurodegener. Dis. 10, 285-293. doi: 10.1159/000335154
19. Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., et al. (2011). Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54, S204-S217. doi: 10.1016/j.neuroimage.2010.06.020
20. La Morgia, C., Ross-Cisneros, F. N., Koronyo, Y., Hannibal, J., Gallassi, R., Cantalupo, G., et al. (2016). Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann. Neurol. 79, 90-109. doi: 10.1002/ana.24548
21. Mirra, S. S., Heyman, A., Mckeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., et al. (1991). The consortium to establish a registry for Alzheimer's disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-479
22. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151, 264-269. doi: 10.7326/0003-4819-151-4-200908180-00135
23. Morrison, A., Polisena, J., Husereau, D., Moulton, K., Clark, M., Fiander, M., et al. (2012). The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int. J. Technol. Assess. Health Care 28, 138-144. doi: 10.1017/S0266462312000086
24. Murayama, S., and Saito, Y. (2004). Neuropathological diagnostic criteria for Alzheimer's disease. Neuropathology 24, 254-260. doi: 10.1111/j.1440-1789.2004.00571.x
25. Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., and Xu, S. (2009). β-amyloid deposition and functional impairment in the retina of the APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 50:793. doi: 10.1167/iovs.08-2384
26. Ramesh, J. K., Anand, R., Veeramanikandan, R., Willayat Yousuf, W., Sudesh, P., Vinod, K. G., et al. (2014). CSF ubiquitin as a specific biomarker in Alzheimer's disease. Curr. Alzheimer Res. 11, 340-348. doi: 10.2174/1567205011666140331161027
27. Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., and Zwinderman, A. H. (2005). Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J. Clin. Epidemiol. 58, 982-990. doi: 10.1016/j.jclinepi.2005.02.022
28. Rutter, C. M., and Gatsonis, C. A. (2001). A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat. Med. 20, 2865-2884. doi: 10.1002/sim.942
29. Schön, C., Hoffmann, N. A., Ochs, S. M., Burgold, S., Filser, S., Steinbach, S., et al. (2012). Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS ONE 7:e53547. doi: 10.1371/journal.pone.0053547
30. Sisodia, S. S., and Price, D. L. (1995). Role of the beta-amyloid protein in Alzheimer's disease. FASEB J. 9, 366-370
31. Tsai, Y., Lu, B., Ljubimov, A. V., Girman, S., Ross-Cisneros, F. N., Sadun, A. A., et al. (2014). Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 55, 523. doi: 10.1167/iovs.13-12888
32. Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., et al. (2011). QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155, 529-536. doi: 10.7326/0003-4819-155-8-201110180-00009
33. Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., et al. (2016). Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 15, 455-532. doi: 10.1016/S1474-4422(16)00062-4